Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 May;67(5):1451–1456. doi: 10.1172/JCI110174

Release of somatostatin-like immunoreactivity from the perfused canine thyroid. Selective stimulatory effect of calcium ions.

P Laurberg, H Orskov
PMCID: PMC370712  PMID: 6112241

Abstract

It is well accepted that the C cells of the thyroid contain somatostatin, but the role in local endocrine function has not yet been firmly established in this organ, and it has not been proved that thyroidal somatostatin is released into the circulation. We have measured the contents of somatostatin-like immunoreactivity in the effluent of canine thyroid glands perfused without recirculation with a synthetic buffer medium. During basal conditions a definite release was consistently found in the order of 10 pg/ml corresponding to 12 pg/min. The somatostatin-like immunoreactivity was studied in dilution experiments and by gel-filtration chromatography, and found to have properties identical to those of synthetic cyclic somatostatin, which was also recovered quantitatively when added to sampling tubes. Various compounds were infused in concentrations that are highly active in pancreas perfusion experiments. 14-min infusion of arginine, 5 and 11.5 mmol/liter; isoproterenol, 10 and 23.7 nmol/liter and 68.7 mumol/liter; acetylcholine, 5 mumol/liter, carbamylcholine, 10 and 100 mumol/liter; glucagon, 1 and 30 nmol/liter; and porcine calcitonin, 1 and 100 ng/ml did not affect the basal release of somatostatin-like immunoreactivity significantly. Neither did an increase from the control level of 4 mmol/liter glucose of 10 or 20 mmol/liter, nor an increase in the control level of 4.4 mmol/liter K+ to 7.5 or 14.4 mmol/liter. Each of these compounds were tested in three or four dogs. The effect of an increase in Ca++ from the control level of 1.5 mmol/liter to 2.25, 3.0, and 4.5 mmol/liter was tested in random order in five thyroid lobes. All three doses elicited an immediate increase in effluent somatostatin-like immunoreactivity. In most experiments the response was biphasic with an early spike, followed by a stable level that was maintained during prolonged Ca++ infusion. The secretory response was not diminished through a series of repeated short pulses of calcium infusion. The response to 3.0 mmol/liter Ca++ (control period 8.4 +/- 1.5, test period 337 +/- 110 pg/ml, mean +/- SE) and 4.5 mmol/liter Ca++ (control period 9.5 +/- 1.4, test period 386 +/- 125) were significantly higher than 2.25 mmol/liter Ca++ (control period 7.2 +/- 1.0 test period 140 +/- 39), while there was no significant difference between responses to the two high doses. Infusion of salmon calcitonin, 10 ng/ml and 1 microgram/ml; or porcine calcitonin, 1 microgram/ml during calcium stimulation (2.25 mmol/liter of Ca++) did not induce alterations in the release of somatostatin-like immunoreactivity. The results demonstrate that thyroidal somatostatin is mobilizable, and it appears to be selectively sensitive to calcium stimulation, indicating a possible role in calcitonin release control.

Full text

PDF
1451

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén B., Ericsson M., Hedner P., Ingemansson S., Westgren U. Somatostatin inhibits thyroid hormone secretion induced by exogenous TSH in man. J Clin Endocrinol Metab. 1978 Nov;47(5):1156–1159. doi: 10.1210/jcem-47-5-1156. [DOI] [PubMed] [Google Scholar]
  2. Ahrén B., Hedner P., Melander A., Westgren U. Inhibition by somatostatin of mouse thyroid activity following stimulation by thyrotrophin, isoprenaline and dibutyryl cyclic-AMP. Acta Endocrinol (Copenh) 1977 Oct;86(2):323–329. doi: 10.1530/acta.0.0860323. [DOI] [PubMed] [Google Scholar]
  3. Alberti K. G., Christensen N. J., Christensen S. E., Hansen A. P., Iversen J., Lundbaek K., Seyer-Hansen K., Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. doi: 10.1016/s0140-6736(73)92873-0. [DOI] [PubMed] [Google Scholar]
  4. Barlet J. P., Garel J. M. Influence de la somatostatine sur le taux plasmatique de calcitonine chez le veau et chex le porc. C R Seances Soc Biol Fil. 1975;169(6):1476–1482. [PubMed] [Google Scholar]
  5. Bloom S. R., Mortimer C. H., Thorner M. O., Besser G. M., Hall R., Gomez-Pan A., Roy V. M., Russell R. C., Coy D. H., Kastin A. J. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet. 1974 Nov 9;2(7889):1106–1109. doi: 10.1016/s0140-6736(74)90869-1. [DOI] [PubMed] [Google Scholar]
  6. Chiba T., Taminato T., Kadowaki S., Abe H., Chihara K., Matsukura S., Goto Y., Seino Y., Fujita T. Effects of insulin and pancreatic polypeptide on gastric somatostatin release. Diabetes. 1980 Apr;29(4):292–295. doi: 10.2337/diab.29.4.292. [DOI] [PubMed] [Google Scholar]
  7. Chiba T., Taminato T., Kadowaki S., Goto Y., Mori K., Seino Y., Abe H., Chihara K., Matsukura S., Fujita T. Effects of [Asu1,7]-eel calcitonin on gastric somatostatin and gastrin release. Gut. 1980 Feb;21(2):94–97. doi: 10.1136/gut.21.2.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cooper C. W., Ramp W. K., Becker D. I., Ontjes D. A. In vitro secretion of immunoreactive rat thyrocalcitonin. Endocrinology. 1977 Jul;101(1):304–311. doi: 10.1210/endo-101-1-304. [DOI] [PubMed] [Google Scholar]
  9. Faber J., Gormsen J., Friis T., Kirkegaard C., Lauridsen U. B., Nerup J., Rogowski P., Siersbaek-Nielsen K. Lack of effect of somatostatin on TSH induced T3 release and platelet function in normal man. Horm Metab Res. 1977 Mar;9(2):165–166. doi: 10.1055/s-0028-1095553. [DOI] [PubMed] [Google Scholar]
  10. Gerich J. E., Patton G. S. Somatostatin. Physiology and clinical applications. Med Clin North Am. 1978 Mar;62(2):375–392. doi: 10.1016/s0025-7125(16)31813-2. [DOI] [PubMed] [Google Scholar]
  11. Gordin A., Lamberg B. A., Pelkonen R., Almqvist S. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 1978 Apr;8(4):289–293. doi: 10.1111/j.1365-2265.1978.tb02771.x. [DOI] [PubMed] [Google Scholar]
  12. Gustavsson S., Lundquist G. Participation of antral somatostatin in the local regulation of gastrin release. Acta Endocrinol (Copenh) 1978 Jun;88(2):339–346. doi: 10.1530/acta.0.0880339. [DOI] [PubMed] [Google Scholar]
  13. Hargis G. K., Williams G. A., Reynolds W. A., Chertow B. S., Kukreja S. C., Bowser E. N., Henderson W. J. Effect of somatostatin on parathyroid hormone and calcitonin secretion. Endocrinology. 1978 Mar;102(3):745–750. doi: 10.1210/endo-102-3-745. [DOI] [PubMed] [Google Scholar]
  14. Hermansen K., Christensen S. E., Orskov H. Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine. Diabetologia. 1979 Apr;16(4):261–266. doi: 10.1007/BF01221953. [DOI] [PubMed] [Google Scholar]
  15. Hermansen K., Christensen S. E., Orskov H. Characterization of somatostatin release from the pancreas: the role of potassium. Scand J Clin Lab Invest. 1979 Dec;39(8):717–722. doi: 10.3109/00365517909108162. [DOI] [PubMed] [Google Scholar]
  16. Ipp E., Dobbs R. E., Arimura A., Vale W., Harris V., Unger R. H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Iversen J. Inhibition of pancreatic glucagon release by somatostatin: in vitro. Scand J Clin Lab Invest. 1974 Apr;33(2):125–129. [PubMed] [Google Scholar]
  18. Kronheim S., Berelowitz M., Pimstone B. L. A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution. Clin Endocrinol (Oxf) 1976 Nov;5(6):619–630. doi: 10.1111/j.1365-2265.1976.tb03865.x. [DOI] [PubMed] [Google Scholar]
  19. Laurberg P. Lack of effect of somatostatin on iodothyronine release from the perfused canine thyroid. Clin Sci (Lond) 1980 Apr;58(4):317–320. doi: 10.1042/cs0580317. [DOI] [PubMed] [Google Scholar]
  20. Laurberg P. T4 and T3 release from the perfused canine thyroid isolated in situ. Acta Endocrinol (Copenh) 1976 Sep;83(1):105–113. doi: 10.1530/acta.0.0830105. [DOI] [PubMed] [Google Scholar]
  21. Laurberg P. The relative contribution of thyroxine and triiodothyronine to the hormone secretion from the perfused canine thyroid during various degrees of stimulation. Endocrinology. 1977 Mar;100(3):656–662. doi: 10.1210/endo-100-3-656. [DOI] [PubMed] [Google Scholar]
  22. Linehan W. M., Cooper C. W., Bolman R. M., 3rd, Wells S. A., Jr Inhibition of in vivo secretion of calcitonin in the pig by somatostin. Endocrinology. 1979 Jun;104(6):1602–1607. doi: 10.1210/endo-104-6-1602. [DOI] [PubMed] [Google Scholar]
  23. Loos U., Raptis S., Birk J., Escobar-Jimenez F., Meyer G., Rothenbuchner G., Pfeiffer E. F. Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1269–1273. doi: 10.1016/0026-0495(78)90057-4. [DOI] [PubMed] [Google Scholar]
  24. Metz S. A., Deftos L. J., Baylink D. J., Robertson R. P. Neuroendocrine modulation of calcitonin and parathyroid hormone in man. J Clin Endocrinol Metab. 1978 Jul;47(1):151–159. doi: 10.1210/jcem-47-1-151. [DOI] [PubMed] [Google Scholar]
  25. Negro-Vilar A., Ojeda S. R., Arimura A., McCann S. M. Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro. Life Sci. 1978 Oct 9;23(14):1493–1497. doi: 10.1016/0024-3205(78)90131-5. [DOI] [PubMed] [Google Scholar]
  26. Parsons J. A., Erlandsen S. L., Hegre O. D., McEvoy R. C., Elde R. P. Central and peripheral localization of somatostatin. Immunoenzyme immunocytochemical studies. J Histochem Cytochem. 1976 Jul;24(7):872–882. doi: 10.1177/24.7.60436. [DOI] [PubMed] [Google Scholar]
  27. Schusdziarra V., Dobbs R. E., Harris V., Unger R. H. Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett. 1977 Sep 1;81(1):69–72. doi: 10.1016/0014-5793(77)80930-7. [DOI] [PubMed] [Google Scholar]
  28. Schusdziarra V., Harris V., Conlon J. M., Arimura A., Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest. 1978 Sep;62(3):509–518. doi: 10.1172/JCI109154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schusdziarra V., Rouiller D., Harris V., Unger R. H. Gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of a meal: effects of truncal vagotomy and atropine in the anesthetized dog. Diabetes. 1979 Jul;28(7):658–663. doi: 10.2337/diab.28.7.658. [DOI] [PubMed] [Google Scholar]
  30. Sorenson R. L., Elde R. P., Seybold V. Effect of norepinephrine on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets. Diabetes. 1979 Oct;28(10):899–904. doi: 10.2337/diab.28.10.899. [DOI] [PubMed] [Google Scholar]
  31. Terry L. C., Rorstad O. P., Martin J. B. The release of biologically and immunologically reactive somatostatin from perifused hypothalamic fragments. Endocrinology. 1980 Sep;107(3):794–800. doi: 10.1210/endo-107-3-794. [DOI] [PubMed] [Google Scholar]
  32. Van Noorden S., Polak J. M., Pearse A. G. Single cellular origin of somatostatin and calcitonin in the rat thyroid gland. Histochemistry. 1977 Aug 22;53(3):243–247. doi: 10.1007/BF00511079. [DOI] [PubMed] [Google Scholar]
  33. Yamada Y., Ito S., Matsubara Y., Kobayashi S. Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids. Tohoku J Exp Med. 1977 May;122(1):87–92. doi: 10.1620/tjem.122.87. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES